These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3296436)

  • 41. Logistics of tumor immunology.
    Kirchner H
    Klin Wochenschr; 1982 Jan; 60(1):37-47. PubMed ID: 6978966
    [No Abstract]   [Full Text] [Related]  

  • 42. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Parenchymatous-stromal interrelations in tumors and methods for their study].
    Dikshteĭn EA; Vasilenko IV
    Arkh Patol; 1987; 49(6):87-94. PubMed ID: 3310971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract]   [Full Text] [Related]  

  • 46. A renaissance for the tumor immunosurveillance hypothesis.
    Lanier LL
    Nat Med; 2001 Nov; 7(11):1178-80. PubMed ID: 11689875
    [No Abstract]   [Full Text] [Related]  

  • 47. The change in tumor aggressiveness with age: lessons from experimental animals.
    Kaesberg PR; Ershler WB
    Semin Oncol; 1989 Feb; 16(1):28-33. PubMed ID: 2645646
    [No Abstract]   [Full Text] [Related]  

  • 48. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J; Johnstone RW; Smyth MJ
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 51. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

  • 52. Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy.
    Zier K; Gansbacher B; Salvadori S
    Immunol Today; 1996 Jan; 17(1):39-45. PubMed ID: 8652051
    [No Abstract]   [Full Text] [Related]  

  • 53. Can the bad guys be defeated?
    Mokyr MB
    Cancer Invest; 1988; 6(1):113-5. PubMed ID: 2966650
    [No Abstract]   [Full Text] [Related]  

  • 54. [Possibility and limitation of immunological therapy for cancer].
    Akiyama T; Kimura T
    Nihon Ishikai Zasshi; 1970 May; 63(9):1189-95. PubMed ID: 5464739
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumors and aging: the influence of age-associated immune changes upon tumor growth and spread.
    Ershler WB
    Adv Exp Med Biol; 1993; 330():77-92. PubMed ID: 8368144
    [No Abstract]   [Full Text] [Related]  

  • 56. A common ground.
    Rivas FV; Su LK
    Trends Immunol; 2015 Apr; 36(4):197. PubMed ID: 25797517
    [No Abstract]   [Full Text] [Related]  

  • 57. Lymphedema and immunocompromised districts.
    Ruocco E; Piccolo V; Russo T; Schwartz RA
    G Ital Dermatol Venereol; 2014 Oct; 149(5):628-9. PubMed ID: 25213390
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunology and cancer.
    Lancet; 1968 Jun; 1(7555):1298-9. PubMed ID: 4172150
    [No Abstract]   [Full Text] [Related]  

  • 59. Cancer and aging.
    Good RA
    Hosp Pract; 1980 Nov; 15(11):10, 15. PubMed ID: 7439905
    [No Abstract]   [Full Text] [Related]  

  • 60. Cancer.
    Curr Opin Immunol; 1991 Oct; 3(5):779-812. PubMed ID: 1755995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.